Table 3 The frequency and persistence of SARS-CoV-2-reactive IgG in the study population 90 days after diagnosis
From: Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population
1st IgG test | 2nd IgG test | p* | |
|---|---|---|---|
Reactive (n = 93) n (%) | Nonreactive (n = 42) n (%) | ||
Reactive (n = 125) | 87 (69.6) | 38 (30.4) | 0.7846 |
Nonreactive (n = 10) | 06 (60.0) | 04 (40.0) | |